These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3816109)

  • 1. Comparison of antibiotic dosage regimens using pharmacokinetic and microbiologic factors.
    Schumacher GE
    Clin Pharm; 1987 Jan; 6(1):59-68. PubMed ID: 3816109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and microbiologic evaluation of dosage regimens for newer cephalosporins and penicillins.
    Schumacher GE
    Clin Pharm; 1983; 2(5):448-57. PubMed ID: 6627874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and microbiologic evaluation of antibiotic dosage regimens.
    Schumacher GE
    Clin Pharm; 1982; 1(1):66-75. PubMed ID: 7184673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using pharmacokinetics in drug therapy. VIII: Pharmacokinetic evaluation of antibiotic dosage regimens.
    Henricks JN; Schumacher GE
    Am J Hosp Pharm; 1980 Oct; 37(10):1356-66. PubMed ID: 7424933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides.
    Deziel-Evans LM; Murphy JE; Job ML
    Clin Pharm; 1986 Apr; 5(4):319-24. PubMed ID: 3709080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-a-day cephalosporins: reality or myth?
    Scaglione F; Dugnani S; Fraschini F
    J Chemother; 1995 May; 7 Suppl 1():13-5. PubMed ID: 8618107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of automatic antimicrobial susceptibility testing with the MS-2 system.
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Catania S; Lancia O; Sorice F
    Boll Ist Sieroter Milan; 1984 May; 63(2):104-10. PubMed ID: 6466451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options in odontogenic infection.
    Maestre-Vera JR
    Med Oral Patol Oral Cir Bucal; 2004; 9 Suppl():25-31; 19-24. PubMed ID: 15580134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.
    McCormack JP; Schentag JJ
    Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriostatic and bactericidal effect of penicillins, cephalosporins, aminoglycosides and ampicillin plus gentamicin compared to trimethoprim plus sulfamethoxazole on "Listeria monocytogenes" (author's transl)].
    Boisivon A
    Ann Microbiol (Paris); 1980; 131B(3):267-76. PubMed ID: 6781393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antibiotics in dental practice.
    Montgomery EH; Kroeger DC
    Dent Clin North Am; 1984 Jul; 28(3):433-53. PubMed ID: 6589179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity in vitro of several aminoglycosides and cephalosporins].
    Piantieri G; Magliulo E; Cafarelli A; Bossi G; Cruciani M
    G Batteriol Virol Immunol; 1981; 74(1-6):77-100. PubMed ID: 7308628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic combination therapy and chemotherapeutic prophylaxis].
    Noseda G
    Schweiz Med Wochenschr; 1975 Mar; 105(9):272-7. PubMed ID: 1124386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity of Salmonella species to four "classical" antibiotics and seven new beta-lactamic antibiotics (author's transl)].
    Roy C; Pellicer MT; Segura C; Foz A
    Med Clin (Barc); 1980 Nov; 75(8):327-30. PubMed ID: 6904743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotics--how do I administer them to my child?].
    Schweiger A
    Fortschr Med; 1997 Feb; 115(6):20, 22-3. PubMed ID: 9173005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.